S100A8⁺ stroma cells predict a good prognosis and inhibit aggressiveness in colorectal carcinoma

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA 2011; 61:69-90; PMID:21296855; http://dx.doi.org/10.3322/caac.20107
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70; PMID:10647931; http://dx.doi.org/10.1016/S0092-8674(00)81683-9
   PubMed Web of Science ®Google Scholar
• Ghavami S, Chitayat S, Hashemi M, Eshraghi M, Chazin WJ, Halayko AJ, Kerkhoff C. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. European J Pharmacol 2009; 625:73-83; PMID:19835859; http://dx.doi.org/10.1016/j.ejphar.2009.08.044
   PubMed Web of Science ®Google Scholar
• Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C, Los M. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukocyte Biol 2008; 83:1484-92; PMID:18339893; http://dx.doi.org/10.1189/jlb.0607397
   PubMed Web of Science ®Google Scholar
• Drews-Elger K, Iorns E, Dias A, Miller P, Ward TM, Dean S, Clarke J, Campion-Flora A, Rodrigues DN, Reis-Filho JS et al. Infiltrating S100A8+myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome. Breast Cancer Res Tr 2014; 148:41-59; PMID:25270120; http://dx.doi.org/10.1007/s10549-014-3122-4
   PubMed Web of Science ®Google Scholar
• Goyette J, Geczy CL. Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids 2011; 41:821-42; PMID:20213444; http://dx.doi.org/10.1007/s00726-010-0528-0
   PubMed Web of Science ®Google Scholar
• Lood C, Stenstrom M, Tyden H, Gullstrand B, Kallberg E, Leanderson T, Truedsson L, Sturfelt G, Ivars F, Bengtsson AA. Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus. Arthritis Res Therapy 2011; 13:R60; PMID:21492422; http://dx.doi.org/10.1186/ar3314
   PubMed Web of Science ®Google Scholar
• Roth J, Vogl T, Sorg C, Sunderkotter C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 2003; 24:155-8; PMID:12697438; http://dx.doi.org/10.1016/S1471-4906(03)00062-0
   PubMed Web of Science ®Google Scholar
• Zhang X, Ai F, Li X, She X, Li N, Tang A, Qin Z, Ye Q, Tian L, Li G et al. Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis. Int J Cancer 2015; 137:2803-14; PMID:26135667; http://dx.doi.org/10.1002/ijc.29671
   Web of Science ®Google Scholar
• Silva EJ, Argyris PP, Zou X, Ross KF, Herzberg MC. S100A8/A9 regulates MMP-2 expression and invasion and migration by carcinoma cells. Int J Biochem Cell Biol 2014; 55:279-87; PMID:25236491; http://dx.doi.org/10.1016/j.biocel.2014.09.007
   PubMed Web of Science ®Google Scholar
• Lim SY, Yuzhalin AE, Gordon-Weeks AN, Muschel RJ. Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells. Oncogene 2016; 35:5735-45; PMID:27086923; http://dx.doi.org/10.1038/onc.2016.107
   Web of Science ®Google Scholar
• Hiratsuka S, Watanabe A, Aburatani H, Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 2006; 8:1369-75; PMID:17128264; http://dx.doi.org/10.1038/ncb1507
   PubMed Web of Science ®Google Scholar
• Fan B, Zhang LH, Jia YN, Zhong XY, Liu YQ, Cheng XJ, Wang XH, Xing XF, Hu Y, Li YA et al. Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer. BMC Cancer 2012; 12:316; PMID:22838504; http://dx.doi.org/10.1186/1471-2407-12-316
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119:1420-8; PMID:19487818; http://dx.doi.org/10.1172/JCI39104
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119:1429-37; PMID:19487819; http://dx.doi.org/10.1172/JCI36183
   PubMed Web of Science ®Google Scholar
• Robson EJD, Khaled WT, Abell K, Watson CJ. Epithelial-to-mesenchymal transition confers resistance to apoptosis in three murine mammary epithelial cell lines. Differentiation 2006; 74:254-64; PMID:16759291; http://dx.doi.org/10.1111/j.1432-0436.2006.00075.x
   PubMed Web of Science ®Google Scholar
• Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R. Tumor budding in colorectal carcinoma: time to take notice. Modern Pathol 2012; 25:1315-25; PMID:22790014; http://dx.doi.org/10.1038/modpathol.2012.94
   PubMed Web of Science ®Google Scholar
• Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002; 40:127-32; PMID:11952856; http://dx.doi.org/10.1046/j.1365-2559.2002.01324.x
   PubMed Web of Science ®Google Scholar
• Prall F, Nizze H, Barten M. Tumour budding as prognostic factor in stage I/II colorectal carcinoma. Histopathology 2005; 47:17-24; PMID:15982319; http://dx.doi.org/10.1111/j.1365-2559.2005.02161.x
   PubMed Web of Science ®Google Scholar
• Hase K, Shatney C, Johnson D, Trollope M, Vierra M. Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum 1993; 36:627-35; PMID:8348847; http://dx.doi.org/10.1007/BF02238588
   PubMed Web of Science ®Google Scholar
• Zlobec I, Lugli A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget 2010; 1:651-61; PMID:21317460; http://dx.doi.org/10.18632/oncotarget.199
   PubMed Web of Science ®Google Scholar
• Stulik J, Osterreicher J, Koupilova K, Knizek  , Macela A, Bures J, Jandík P, Langr F, Dedic K, Jungblut PR. The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumor mass. Electrophoresis 1999; 20:1047-54; PMID:10344284; http://dx.doi.org/10.1002/(SICI)1522-2683(19990101)20:4/5%3c1047::AID-ELPS1047%3e3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Foell D, Hernandez-Rodriguez J, Sanchez M, Vogl T, Cid MC, Roth J. Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis. J Pathol 2004; 204:311-6; PMID:15476267; http://dx.doi.org/10.1002/path.1660
   PubMed Web of Science ®Google Scholar
• Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012; 12:298-306; PMID:22419253; http://dx.doi.org/10.1038/nrc3245
   PubMed Web of Science ®Google Scholar
• Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID:17008531; http://dx.doi.org/10.1126/science.1129139
   PubMed Web of Science ®Google Scholar
• Srikrishna G. S100A8 and S100A9: new insights into their roles in malignancy. J Innate Immunity 2012; 4:31-40; PMID:21912088; http://dx.doi.org/10.1159/000330095
   PubMed Web of Science ®Google Scholar
• Funk S, Mark R, Bayo P, Flechtenmacher C, Grabe N, Angel P, Plinkert PK, Hess J. High S100A8 and S100A12 protein expression is a favorable prognostic factor for survival of oropharyngeal squamous cell carcinoma. Int J Cancer 2015; 136:2037-46; PMID:25302747; http://dx.doi.org/10.1002/ijc.29262
   PubMed Web of Science ®Google Scholar
• Kang JH, Hwang SM, Chung IY. S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal-regulated kinase and nuclear factor-kappa B pathways. Immunology 2015; 144:79-90; PMID:24975020; http://dx.doi.org/10.1111/imm.12352
   PubMed Web of Science ®Google Scholar
• Gebhardt C, Nemeth J, Angel P, Hess J. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 2006; 72:1622-31; PMID:16846592; http://dx.doi.org/10.1016/j.bcp.2006.05.017
   PubMed Web of Science ®Google Scholar
• De Filippo K, Neill DR, Mathies M, Bangert M, McNeill E, Kadioglu A, Hogg N. A new protective role for S100A9 in regulation of neutrophil recruitment during invasive pneumococcal pneumonia. FASEB J 2014; 28:3600-8; PMID:24776746; http://dx.doi.org/10.1096/fj.13-247460
   PubMed Web of Science ®Google Scholar
• Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2:647-56; PMID:12209154; http://dx.doi.org/10.1038/nrc883
   PubMed Web of Science ®Google Scholar
• Yui S, Nakatani Y, Mikami M. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharmaceutical Bulletin 2003; 26:753-60; PMID:12808281; http://dx.doi.org/10.1248/bpb.26.753
   PubMed Web of Science ®Google Scholar
• Ghavami S, Kerkhoff C, Los M, Hashemi M, Sorg C, Karami-Tehrani F. Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J Leukocyte Biol 2004; 76:169-75; PMID:15075348; http://dx.doi.org/10.1189/jlb.0903435
   PubMed Web of Science ®Google Scholar
• Zali H, Rezaei-Tavirani M, Kariminia A, Yousefi R, Shokrgozar MA. Evaluation of growth inhibitory and apoptosis inducing activity of human calprotectin on the human gastric cell line (AGS). Iranian Biomed J 2008; 12:7-14; PMID:18392090
   PubMedGoogle Scholar
• Ichikawa M, Williams R, Wang L, Vogl T, Srikrishna G. S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res 2011; 9:133-48; PMID:21228116; http://dx.doi.org/10.1158/1541-7786.MCR-10-0394
   PubMed Web of Science ®Google Scholar
• Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, Nguyen M, Olsson A, Nawroth PP, Bierhaus A et al. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 2008; 29:2035-43; PMID:18689872; http://dx.doi.org/10.1093/carcin/bgn188
   PubMed Web of Science ®Google Scholar
• Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007; 13:1042-9; PMID:17767165; http://dx.doi.org/10.1038/nm1638
   PubMed Web of Science ®Google Scholar
• Newton RA, Hogg N. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 1998; 160:1427-35; PMID:9570563
   PubMed Web of Science ®Google Scholar
• Viemann D, Strey A, Janning A, Jurk K, Klimmek K, Vogl T, Hirono K, Ichida F, Foell D, Kehrel B et al. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 2005; 105:2955-62; PMID:15598812; http://dx.doi.org/10.1182/blood-2004-07-2520
   PubMed Web of Science ®Google Scholar
• Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, Tessier PA. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol 2003; 171:2602-9; PMID:12928412; http://dx.doi.org/10.4049/jimmunol.171.5.2602
   PubMed Web of Science ®Google Scholar
• Duan L, Wu R, Ye L, Wang H, Yang X, Zhang Y, Weng Y, Luo J, Tang M, Shi Q et al. S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/beta-catenin pathway. PLoS One 2013; 8:e62092; PMID:23637971; http://dx.doi.org/10.1371/journal.pone.0062092
   PubMed Web of Science ®Google Scholar
• Yin C, Li H, Zhang B, Liu Y, Lu G, Lu S, Sun L, Qi Y, Li X, Chen W. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition. Breast Cancer Res Treat 2013; 142:297-309; PMID:24177755; http://dx.doi.org/10.1007/s10549-013-2737-1
   PubMed Web of Science ®Google Scholar
• Andres Cerezo L, Mann H, Pecha O, Plestilova L, Pavelka K, Vencovsky J, Senolt L. Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther 2011; 13:R122; PMID:21791097; http://dx.doi.org/10.1186/ar3426
   PubMed Web of Science ®Google Scholar
• Pepper RJ, Hamour S, Chavele KM, Todd SK, Rasmussen N, Flint S, Lyons PA, Smith KG, Pusey CD, Cook HT et al. Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis. Kidney Int 2013; 83:1150-8; PMID:23423260; http://dx.doi.org/10.1038/ki.2013.2
   PubMed Web of Science ®Google Scholar
• Zlobec I, Lugli A. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J Gastroenterol 2009; 15:5898-906; PMID:20014453; http://dx.doi.org/10.3748/wjg.15.5898
   PubMed Web of Science ®Google Scholar
• Zlobec I, Lugli A, Baker K, Roth S, Minoo P, Hayashi S, Terracciano L, Jass JR. Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer. J Pathol 2007; 212:260-8; PMID:17516584; http://dx.doi.org/10.1002/path.2164
   PubMed Web of Science ®Google Scholar
• Wang L, Lin D, Fu Y, Lai M. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma. Pathol Res Practice 2016; 212:791-9; PMID:27461829; http://dx.doi.org/10.1016/j.prp.2016.06.009
   Web of Science ®Google Scholar
• Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K, Morimatsu M. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 1989; 63:539-43
   PubMed Web of Science ®Google Scholar
• Kong J, Sun W, Li C, Wan L, Wang S, Wu Y, Xu E, Zhang H, Lai M. Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6. Cancer Lett 2016; 380:476-84; PMID:27443606; http://dx.doi.org/10.1016/j.canlet.2016.07.015
   PubMed Web of Science ®Google Scholar
• Ruan W, Zhu S, Wang H, Xu F, Deng H, Ma Y, Lai M. IGFBP-rP1, a potential molecule associated with colon cancer differentiation. Mol Cancer 2010; 9:281; PMID:20977730; http://dx.doi.org/10.1186/1476-4598-9-281
   PubMed Web of Science ®Google Scholar